Über den Autor Nawab John (Hrsg.) Dar
Dr. Nawab John Dar is a scientist at the Salk Institute for Biological Studies in La Jolla, California, where he is part of a research group led by Professor Pamela Maher. His research journey began after graduating from the CSIR-Indian Institute of Integrative Medicine in India, and he has since been dedicated to advancing the understanding of neurodegenerative disorders, particularly Alzheimer's disease. Dr. Dar's work focuses on exploring the neuroprotective potential of bioactive compounds and investigating the role of oxytosis/ferroptosis in Alzheimer's disease. His goal is to identify targets for effective therapies against Alzheimer's. Driven by a passion for unraveling the complexities of the human brain, Dr. Dar has made significant contributions to the field of neuroscience. His dedication to research and education has been recognized by his inclusion in the Marquis Who's Who in America list. Beyond his scientific endeavors, Dr. Dar is a committed educator and advocate for raising awareness about neurodegenerative diseases, emphasizing the importance of small molecules in targeting various aspects of neurodegeneration. His work not only sheds light on the potential of these molecules but also offers hope for effective treatments for millions affected by these conditions.Dr. Shahnawaz Ali Bhat is an assistant professor in the Department of Zoology at Aligarh Muslim University (AMU), Aligarh, India. Currently his research program focuses on deciphering the molecular and cellular processes/pathways involved in the pathogenesis of neurodegenerative diseases and metabolic disorders. Further, he is also interested in neuropharmacological and neurotoxicological studies to screen or identify various bioactive molecules for effective prevention of neurodegenerative diseases and hypertension-induced neurodegeneration Dr. Showkat Ahmad Dar is an experienced bioinformatician specializing in computational biology, machine learning, and big data analysis, with a strong publication record. His expertise encompasses the thorough analysis of high-throughput data, including next-generation sequencing (NGS) and related datasets, mutational profiling, and the integration of multi-omics data to improve therapeutic strategies, particularly for high-risk malignancies. Dr. Showkat has developed complex computational pipelines and machine learning models and possesses significant skills in statistical analysis. At the NIH, he has conducted computational and statistical analyses to identify genetic, epigenetic, and other disease-relevant factors influencing transcription. He excels in linking multiomics data with clinical and environmental information and has a proven track record of publishing scientific findings, presenting at conferences, and mentoring trainees. Dr. Showkat is highly motivated to contribute to innovative translational research at the intersection of high-throughput data applications, computational biology, and clinical applications.